Preoperative Radiographic Assessment of Hepatic Steatosis with Histologic Correlation
Authors:
- Sean CurranSCSean Curran
- Lawrence H. SchwartzLSLawrence H. Schwartz
- David A. KoobyDKDavid A. Kooby
- David S. KlimstraDKDavid S. Klimstra
- Jinru ShiaJSJinru Shia
- Alejandro MunozAMAlejandro Munoz
- Yuman FongYFYuman Fong
- William R. JarnaginWJWilliam R. Jarnagin
- Ronald P. DeMatteoRDRonald P. DeMatteo
- Leslie H. BlumgartLBLeslie H. Blumgart
- Michael I. D'ANgelicaMDMichael I. D'ANgelica
- 1 March 2008
- journal article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 206 (3) , 480-488
Abstract
The adverse impact of hepatic steatosis on perioperative outcomes after liver resection is gaining recognition. But the accuracy of preoperative radiologic assessment of fatty liver disease remains unclear. The objective of this study was to correlate preoperative radiologic estimation with postoperative histologic measurement of steatosis. Patients who underwent partial hepatectomy between 1997 and 2001, with complete preoperative radiographic imaging and postoperative pathologic assessment of steatosis, were retrospectively analyzed. The presence of steatosis was assessed radiographically using noncontrast-enhanced CT (NCCT), contrast-enhanced CT (CCT), or MRI, using standard quantitative radiologic criteria. Repeat histologic analysis was used to quantify the extent of hepatic steatosis. One hundred thirty-one patients were studied. The overall sensitivity and specificity for all imaging modalities in detecting pathologically confirmed hepatic steatosis were 56% and 82%, respectively. Sensitivity and specificity for NCCT, CCT, and MRI using standard quantitative criteria were 33% and 100%, 50% and 83%, and 88%, and 63%, respectively. Increasing body mass indices adversely affected the accuracy of NCCT (p=0.002). Preoperative chemotherapy did not notably affect radiologic accuracy. The presence of a fatty-appearing liver on NCCT scans indicates clinically significant steatosis, but steatosis cannot be excluded based on a normal NCCT scan, particularly in obese patients. Conversely, normal MRI helps to exclude hepatic steatosis, but abnormal MRI is not a reliable indicator of fatty change. CCT is not an effective means of identifying steatosis. We conclude that, when used alone, conventional cross-sectional imaging does not consistently permit accurate identification of hepatic steatosis.Keywords
This publication has 28 references indexed in Scilit:
- Severe Steatosis Increases Hepatocellular Injury and Impairs Liver Regeneration in a Rat Model of Partial HepatectomyAnnals of Surgery, 2007
- Steatosis as a Risk Factor in Liver SurgeryAnnals of Surgery, 2007
- Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal MetastasesJournal of Clinical Oncology, 2006
- CASH (Chemotherapy-Associated Steatohepatitis) CostsAnnals of Surgery, 2006
- Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver MetastasesAnnals of Surgery, 2006
- Hepatic MRI for Fat QuantitationJournal of Clinical Gastroenterology, 2005
- Preoperative Portal Vein Embolization for Extended HepatectomyAnnals of Surgery, 2003
- Body mass index as a predictor of hepatic steatosis in living liver donorsLiver Transplantation, 2001
- Enhanced tumor detection in the presence of fatty liver disease: Cell-specific contrast agentsJournal of Magnetic Resonance Imaging, 1994
- THE EFFECTS OF COLD PRESERVATION ON STEATOTIC GRAFT VIABILITY IN RAT LIVER TRANSPLANTATIONTransplantation, 1993